BioScrip (BIOS)
Create an Alert
15.98
+0.19 +1.20%
NASDAQ
Jun 18, 5:00PM
BATS Real time
Currency in USD
BioScrip Debt to Equity Ratio:
0.8814 for March 31, 2013BioScrip Historical Debt to Equity Ratio Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.8814 |
| Dec. 31, 2012 | 0.7715 |
| Sept. 30, 2012 | 0.7987 |
| June 30, 2012 | 0.873 |
| March 31, 2012 | 1.357 |
| Dec. 31, 2011 | 1.363 |
| Sept. 30, 2011 | 1.351 |
| June 30, 2011 | 1.343 |
| March 31, 2011 | 1.36 |
| Dec. 31, 2010 | 1.532 |
| Sept. 30, 2010 | 1.199 |
| June 30, 2010 | 1.228 |
| March 31, 2010 | 1.255 |
| Dec. 31, 2009 | 0.1951 |
| Sept. 30, 2009 | 0.3512 |
| June 30, 2009 | 0.3482 |
| March 31, 2009 | 0.3627 |
| Dec. 31, 2008 | 0.5566 |
| Sept. 30, 2008 | 0.3206 |
| June 30, 2008 | 0.117 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
BIOS Debt to Equity Ratio Benchmarks
| Companies | |
|---|---|
| Abbott Laboratories | 0.3144 |
| Daiichi Sankyo | 0.3006 |
| Astellas Pharma | 0.00 |
BIOS Debt to Equity Ratio Rankings
| Overall |
61st percentile 6386 of 16770 |
| Sector |
54th percentile 647 of 1408 in Healthcare |
| Industry |
56th percentile 59 of 135 in Drug Manufacturers - Major |
BIOS Debt to Equity Ratio Range, Past 5 Years
| Minimum | 0.1170 | Jun 2008 |
| Maximum | 1.532 | Dec 2010 |
| Average | 0.8782 |
